サマリー

神経学バイオマーカーの世界市場 2023-2027
神経学バイオマーカー市場は、2022-2027年に6917.68百万米ドルの成長が予測され、予測期間中のCAGRは12.88%で加速すると予測されています。当レポートでは、神経学的バイオマーカー市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。神経疾患の罹患率の増加、神経疾患特異的バイオマーカーの臨床試験の増加、政府や医療機関による取り組みや支援の増加が市場を牽引しています。
Technavioの神経疾患バイオマーカー市場は以下のようにセグメント化されています：
適応症別
- アルツハイマー病
- PD
- ASD
- MS
- その他
エンドユーザー別
- 病院
- 臨床診断センター
- 研究機関、その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、正確な神経学的診断への注目が高まっていることが、今後数年間の神経学的バイオマーカー市場の成長を促進する主な理由の1つであると特定している。また、神経疾患に対する血液ベースのバイオマーカーが利用可能になり、マニュアルmiRNAの進化が市場の大きな需要につながる。
神経学的バイオマーカー市場に関するレポートは以下の分野をカバーしています：
- 神経学的バイオマーカー市場のサイジング
- 神経学的バイオマーカー市場予測
- 神経学的バイオマーカー市場の業界分析
本レポートでは、神経学的バイオマーカー市場の主要ベンダー（Abbott Laboratories、ACROBIOSYSTEMS INC.、Advanced Brain Monitoring Inc.、Bio Rad Laboratories Inc、bioMerieux SA、Charles River Laboratories International Inc.、EATRIS ERIC、Eli Lilly and Co.、Enzo Biochem Inc.、F. Hoffmann La Roche Ltd.、HU Group Holdings Inc.、Merck KGaA、Metabolon Inc.、Proteome Sciences plc、QIAGEN NV、Quanterix Corp.、Quest Diagnostics Inc.、Thermo Fisher Scientific Inc.、IQVIA Holdings Inc.、PerkinElmer Inc.などです。また、神経バイオマーカー市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neurological-biomarkers-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global neurological biomarkers market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global neurological biomarkers market 2017 - 2021 ($ million)
o 4.2 Indication Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Indication
o 6.1 Market segments
o Exhibit 30: Chart on Indication - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Indication - Market share 2022-2027 (%)
o 6.2 Comparison by Indication
o Exhibit 32: Chart on Comparison by Indication
o Exhibit 33: Data Table on Comparison by Indication
o 6.3 AD - Market size and forecast 2022-2027
o Exhibit 34: Chart on AD - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on AD - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on AD - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on AD - Year-over-year growth 2022-2027 (%)
o 6.4 PD - Market size and forecast 2022-2027
o Exhibit 38: Chart on PD - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on PD - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on PD - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on PD - Year-over-year growth 2022-2027 (%)
o 6.5 ASD - Market size and forecast 2022-2027
o Exhibit 42: Chart on ASD - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on ASD - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on ASD - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on ASD - Year-over-year growth 2022-2027 (%)
o 6.6 MS - Market size and forecast 2022-2027
o Exhibit 46: Chart on MS - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on MS - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on MS - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on MS - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Indication
o Exhibit 54: Market opportunity by Indication ($ million)
o Exhibit 55: Data Table on Market opportunity by Indication ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 58: Chart on Comparison by End-user
o Exhibit 59: Data Table on Comparison by End-user
o 7.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 60: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 7.4 Clinical diagnostic centers - Market size and forecast 2022-2027
o Exhibit 64: Chart on Clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
o 7.5 Research organizations and others - Market size and forecast 2022-2027
o Exhibit 68: Chart on Research organizations and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Research organizations and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Research organizations and others - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Research organizations and others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 72: Market opportunity by End-user ($ million)
o Exhibit 73: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share by geography 2022-2027 (%)
o Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 111: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 115: Market opportunity by geography ($ million)
o Exhibit 116: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 ACROBIOSYSTEMS INC.
o Exhibit 123: ACROBIOSYSTEMS INC. - Overview
o Exhibit 124: ACROBIOSYSTEMS INC. - Product / Service
o Exhibit 125: ACROBIOSYSTEMS INC. - Key offerings
o 12.4 Bio Rad Laboratories Inc.
o Exhibit 126: Bio Rad Laboratories Inc. - Overview
o Exhibit 127: Bio Rad Laboratories Inc. - Business segments
o Exhibit 128: Bio Rad Laboratories Inc. - Key news
o Exhibit 129: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 130: Bio Rad Laboratories Inc. - Segment focus
o 12.5 bioMerieux SA
o Exhibit 131: bioMerieux SA - Overview
o Exhibit 132: bioMerieux SA - Product / Service
o Exhibit 133: bioMerieux SA - Key offerings
o 12.6 Charles River Laboratories International Inc.
o Exhibit 134: Charles River Laboratories International Inc. - Overview
o Exhibit 135: Charles River Laboratories International Inc. - Business segments
o Exhibit 136: Charles River Laboratories International Inc. - Key news
o Exhibit 137: Charles River Laboratories International Inc. - Key offerings
o Exhibit 138: Charles River Laboratories International Inc. - Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus
o 12.8 HU Group Holdings Inc.
o Exhibit 144: HU Group Holdings Inc. - Overview
o Exhibit 145: HU Group Holdings Inc. - Product / Service
o Exhibit 146: HU Group Holdings Inc. - Key offerings
o 12.9 IQVIA Holdings Inc.
o Exhibit 147: IQVIA Holdings Inc. - Overview
o Exhibit 148: IQVIA Holdings Inc. - Business segments
o Exhibit 149: IQVIA Holdings Inc. - Key news
o Exhibit 150: IQVIA Holdings Inc. - Key offerings
o Exhibit 151: IQVIA Holdings Inc. - Segment focus
o 12.10 Merck KGaA
o Exhibit 152: Merck KGaA - Overview
o Exhibit 153: Merck KGaA - Business segments
o Exhibit 154: Merck KGaA - Key news
o Exhibit 155: Merck KGaA - Key offerings
o Exhibit 156: Merck KGaA - Segment focus
o 12.11 Metabolon Inc.
o Exhibit 157: Metabolon Inc. - Overview
o Exhibit 158: Metabolon Inc. - Product / Service
o Exhibit 159: Metabolon Inc. - Key offerings
o 12.12 PerkinElmer Inc.
o Exhibit 160: PerkinElmer Inc. - Overview
o Exhibit 161: PerkinElmer Inc. - Business segments
o Exhibit 162: PerkinElmer Inc. - Key news
o Exhibit 163: PerkinElmer Inc. - Key offerings
o Exhibit 164: PerkinElmer Inc. - Segment focus
o 12.13 Proteome Sciences plc
o Exhibit 165: Proteome Sciences plc - Overview
o Exhibit 166: Proteome Sciences plc - Product / Service
o Exhibit 167: Proteome Sciences plc - Key offerings
o 12.14 QIAGEN NV
o Exhibit 168: QIAGEN NV - Overview
o Exhibit 169: QIAGEN NV - Product / Service
o Exhibit 170: QIAGEN NV - Key news
o Exhibit 171: QIAGEN NV - Key offerings
o 12.15 Quanterix Corp.
o Exhibit 172: Quanterix Corp. - Overview
o Exhibit 173: Quanterix Corp. - Product / Service
o Exhibit 174: Quanterix Corp. - Key offerings
o 12.16 Quest Diagnostics Inc.
o Exhibit 175: Quest Diagnostics Inc. - Overview
o Exhibit 176: Quest Diagnostics Inc. - Business segments
o Exhibit 177: Quest Diagnostics Inc. - Key offerings
o Exhibit 178: Quest Diagnostics Inc. - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 179: Thermo Fisher Scientific Inc. - Overview
o Exhibit 180: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 181: Thermo Fisher Scientific Inc. - Key news
o Exhibit 182: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 183: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global neurological biomarkers market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Indication - Market share 2022-2027 (%)
Exhibits31: Data Table on Indication - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Indication
Exhibits33: Data Table on Comparison by Indication
Exhibits34: Chart on AD - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on AD - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on AD - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on AD - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on PD - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on PD - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on PD - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on PD - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on ASD - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on ASD - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on ASD - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on ASD - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on MS - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on MS - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on MS - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on MS - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Indication ($ million)
Exhibits55: Data Table on Market opportunity by Indication ($ million)
Exhibits56: Chart on End-user - Market share 2022-2027 (%)
Exhibits57: Data Table on End-user - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Clinical diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Clinical diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Research organizations and others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Research organizations and others - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Research organizations and others - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Research organizations and others - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by End-user ($ million)
Exhibits73: Data Table on Market opportunity by End-user ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share by geography 2022-2027 (%)
Exhibits76: Data Table on Market share by geography 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity by geography ($ million)
Exhibits116: Data Tables on Market opportunity by geography ($ million)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: ACROBIOSYSTEMS INC. - Overview
Exhibits124: ACROBIOSYSTEMS INC. - Product / Service
Exhibits125: ACROBIOSYSTEMS INC. - Key offerings
Exhibits126: Bio Rad Laboratories Inc. - Overview
Exhibits127: Bio Rad Laboratories Inc. - Business segments
Exhibits128: Bio Rad Laboratories Inc. - Key news
Exhibits129: Bio Rad Laboratories Inc. - Key offerings
Exhibits130: Bio Rad Laboratories Inc. - Segment focus
Exhibits131: bioMerieux SA - Overview
Exhibits132: bioMerieux SA - Product / Service
Exhibits133: bioMerieux SA - Key offerings
Exhibits134: Charles River Laboratories International Inc. - Overview
Exhibits135: Charles River Laboratories International Inc. - Business segments
Exhibits136: Charles River Laboratories International Inc. - Key news
Exhibits137: Charles River Laboratories International Inc. - Key offerings
Exhibits138: Charles River Laboratories International Inc. - Segment focus
Exhibits139: F. Hoffmann La Roche Ltd. - Overview
Exhibits140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits141: F. Hoffmann La Roche Ltd. - Key news
Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits144: HU Group Holdings Inc. - Overview
Exhibits145: HU Group Holdings Inc. - Product / Service
Exhibits146: HU Group Holdings Inc. - Key offerings
Exhibits147: IQVIA Holdings Inc. - Overview
Exhibits148: IQVIA Holdings Inc. - Business segments
Exhibits149: IQVIA Holdings Inc. - Key news
Exhibits150: IQVIA Holdings Inc. - Key offerings
Exhibits151: IQVIA Holdings Inc. - Segment focus
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Metabolon Inc. - Overview
Exhibits158: Metabolon Inc. - Product / Service
Exhibits159: Metabolon Inc. - Key offerings
Exhibits160: PerkinElmer Inc. - Overview
Exhibits161: PerkinElmer Inc. - Business segments
Exhibits162: PerkinElmer Inc. - Key news
Exhibits163: PerkinElmer Inc. - Key offerings
Exhibits164: PerkinElmer Inc. - Segment focus
Exhibits165: Proteome Sciences plc - Overview
Exhibits166: Proteome Sciences plc - Product / Service
Exhibits167: Proteome Sciences plc - Key offerings
Exhibits168: QIAGEN NV - Overview
Exhibits169: QIAGEN NV - Product / Service
Exhibits170: QIAGEN NV - Key news
Exhibits171: QIAGEN NV - Key offerings
Exhibits172: Quanterix Corp. - Overview
Exhibits173: Quanterix Corp. - Product / Service
Exhibits174: Quanterix Corp. - Key offerings
Exhibits175: Quest Diagnostics Inc. - Overview
Exhibits176: Quest Diagnostics Inc. - Business segments
Exhibits177: Quest Diagnostics Inc. - Key offerings
Exhibits178: Quest Diagnostics Inc. - Segment focus
Exhibits179: Thermo Fisher Scientific Inc. - Overview
Exhibits180: Thermo Fisher Scientific Inc. - Business segments
Exhibits181: Thermo Fisher Scientific Inc. - Key news
Exhibits182: Thermo Fisher Scientific Inc. - Key offerings
Exhibits183: Thermo Fisher Scientific Inc. - Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations